Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Improved Antibodies Against ErbB4/Her4

Posted Jun 07 2009 5:00pm

Description of Invention:
ErbB4/Her4 is a receptor tyrosine kinase that regulates cell proliferation, cell differentiation and cell survival. ErbB4 has been implicated in the pathology of numerous cancers (e.g., breast cancer, non-small cell lung carcinoma, adenocarcinoma), as well as psychiatric disorders (e.g., schizophrenia). As a result, ErbB4 is an excellent target for developing therapies against these diseases. Unfortunately, the study of ErbB4 has been slowed by the lack of highly specific and functional antibodies against the receptor.

In order to overcome the deficiencies with current ErbB4 antibodies, NIH inventors have generated three rabbit monoclonal antibodies with improved properties and versatility. Specifically, the mAb-6, mAb-7 and mAb-10 hybridomas produce antibodies with a high degree of specificity and affinity for ErbB4. These antibodies recognize specific epitopes on the intracellular domains of ErbB4 without cross-reaction against other proteins, and can be used successfully in the immunostaining of fixed tissue. Each antibody recognizes both human and mouse ErbB4, whereas only mAb-7 and mAb-10 recognize rat ErbB4.

Applications:
  • Basic research tool for the study of ErbB4
  • Reagent for diagnostic applications such as Western Blotting, ELISA, immunofluorescence and immunohistochemistry in fixed tissue samples
  • Reagent for biochemical techniques such as immunoprecipitation


Advantages:
  • Potential to be the gold standard for ErbB4 antibodies due to its specificity and affinity
  • Greater affinity for ErbB4 than currently available antibodies, giving them superior properties in diagnostic and biochemical applications
  • Unlike currently available polyclonal antibodies to ErbB4, the monoclonal antibodies do not cross-react with other proteins
  • Unlike currently available antibodies, these antibodies are capable of immunostaining fixed tissue samples
  • The epitopes on ErbB4 that are recognized by each monoclonal antibody have been mapped


Inventors:
Andres L Buonanno (NICHD)
Detlef Vullhorst (NCI)


Patent Status:
HHS, Reference No. E-171-2009/0

Research Material -- patent protection is not being pursued for this technology

Relevant Publication:
  1. G Carpenter. ErbB-4: mechanism of action and biology. Exp Cell Res. 2003 Mar 10;284(1):66-77. [ PubMed abs ]
  2. S Britsch. The neruregulin-1/ErbB signaling system in development and disease. Adv Anat Embryol Cell Biol. 2007;190:1-65. [ PubMed abs ]


Licensing Status:
Available under a biological materials license.

Collaborative Research Opportunity:
The Eunice Kennedy Shriever National Institute of Child Health and Human Development, Section on Molecular Neurobiology, is seeking statements of capability or interest from parties interested in collaborative research to further evaluate or commercialize specific rabbit monoclonal antibodies generated against the ErbB4 receptor (also known as HER4). Please contact Joseph Conrad III, Ph.D. at 301-435-3107 or jmconrad@mail.nih.gov for more information.


Portfolios:
Cancer
Cancer - Research Materials
Central Nervous System
Central Nervous System - Research Materials



For Additional Information Please Contact:
Patrick McCue Ph.D.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: McCuepat@mail.nih.gov
Phone: 301-496-7057
Fax: 301-402-0220


Ref No: 1966

Updated: 06/2009

Post a comment
Write a comment:

Related Searches